2m 2m 2m 2m 2m 2m 2m
Exelixis (EXEL)
NASDAQ
$51.16-$0.19 (-0.36%)
Price as of Jun 23, 2026 9:57 AM EDT- $12.9BMarket Cap
- 18.40%1-Year Change
- BiotechnologyIndustry
Exelixis (EXEL)
$51.16-$0.19 (-0.36%)
EXEL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $51.35 | ||
Change | -$0.56 (-1.08%) | ||
Open | $52.00 | ||
High | $52.95 | ||
Low | $50.80 | ||
Previous Close | $51.91 | ||
Volume | 3,504,387 | ||
30-Day Average Volume | 2,635,280 | ||
1-Week Change | -3.11% | ||
1-Month Change | 2.39% | ||
1-Year Change | 18.40% | ||
3-Year Change | 158.30% | ||
5-Year Change | 124.92% | ||
Fundamentals | |||
Shares Outstanding | 251.4M | ||
Total Assets | $2.6B | ||
Market Cap | $12.9B | ||
Enterprise Value | $12.7B | ||
Period: QTR TTM FY | |||
Revenue | $555.0M | ||
Net Income | $210.5M | ||
Free Cash Flow | $250.3M | ||
EBIT | $267.7M | ||
EBITDA | $274.6M | ||
Net Working Capital | $837.7M | ||
EPS | $0.79 | ||
Enterprise Value/EBITDA | 46 | ||
Enterprise Value/Revenue | 23 | ||
P/B | 7 | ||
P/E | 65 | ||
PEG | -6 | ||
Price/Free Cash Flow | 52 | ||
Price/Operating Cash Flow | 51 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue